Clinical trial
Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With…
NCT00003315 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00003315 |
|---|---|
| Title | Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection |
| Official title | Supplementary Protocol for Patients With Invasive Fungal Infection, Entered Into AML 11, AML 12 and UKALL XII (Or Their Successors) |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection |
| Intervention type | Biological, Drug |
| Interventions | sargramostim, liposomal amphotericin B |
| Enrollment | 200 |
| Start date | Jul 1, 1997 |
| Completion | Dec 1, 1997 |
| First posted | Aug 26, 2004 |
| Last update posted | Dec 4, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: